Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / American Depositary Shares, each representing 1 Ordinary Shares
-
Shares outstanding
-
100M
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
13.1M
-
Shares change
-
-286K
-
Total reported value, excl. options
-
$136M
-
Value change
-
-$8.88M
-
Number of buys
-
30
-
Number of sells
-
-25
-
Price
-
$10.40
Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q3 2019
72 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q3 2019.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.1M shares
of 100M outstanding shares and own 13.06% of the company stock.
Largest 10 shareholders include FMR LLC (3.46M shares), Sumitomo Mitsui Trust Holdings, Inc. (1.31M shares), Nikko Asset Management Americas, Inc. (1.31M shares), ARK Investment Management LLC (1.24M shares), Capital World Investors (875K shares), Capital International Investors (710K shares), MORGAN STANLEY (696K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (575K shares), CITADEL ADVISORS LLC (508K shares), and CREDIT SUISSE AG/ (460K shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.